Standard Biotools reported $27.93M in Operating Expenses for its fiscal quarter ending in June of 2026.





Operating Expenses Change Date
Agilent USD 1.43B 2M Jun/2026
Becton, Dickinson and Co. USD 4.16B 20.25B Sep/2026
Bio-Rad Laboratories USD 7.6B 429.1M Sep/2026
Bruker USD 790.5M 21.6M Sep/2026
Danaher USD 53.62B 1.04B Sep/2026
Illumina USD 525M 374M Sep/2026
Myriad Genetics USD 212.8M 16.2M Dec/2025
Nikon Corporation JPY 160.58B 4.6B Sep/2026
Pacific Biosciences Of California USD 97.83M 41.29M Dec/2025
Revvity USD 604.27M 719K Sep/2026
Roche Holding CHF 18.9B 2.12B Jun/2026
Sony JPY 2.78T 421.05B Sep/2026
Standard Biotools USD 27.93M 2.63M Jun/2026
Thermo Fisher Scientific USD 9.68B 134M Sep/2026
Waters USD 527M 592M Jun/2026